ZLABZai Lab Limited

$2B

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$37M+235.9% YoY

Gross Profit

-$116M-314.5% margin

Operating Income

-$171M-461.8% margin

Net Income

-$163M-442.2% margin

EPS (Diluted)

$-17.60

QoQ Revenue Growth

+83.7%

Cash Flow

Operating Cash Flow

-$66M

Free Cash Flow

-$70M

Stock-Based Comp.

$10M

Balance Sheet

Total Assets

$1.9B

Total Liabilities

$224M

Stockholders' Equity

$1.7B

Cash & Equivalents

$1.8B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$37M	$11M	+235.9%
Gross Profit	-$116M	$8M	-1534.2%
Operating Income	-$171M	-$84M	-103.1%
Net Income	-$163M	-$81M	-102.6%

Revenue Segments

Zejula

$23M71%

Optune

$10M29%

Qinlock

$4,0340%

ZLAB Q2 2021 Earnings — Zai Lab Limited Revenue & Financial Results | Market Cap Arena